Amalgamated Financial’s Phibro Animal Health PAHC Stock Holding History

Amalgamated Financial’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$198K	Buy	+9,937	New	+$201K	﹤0.01%	1903

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amalgamated Financial's PAHC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Phibro Animal Health (PAHC) in Q1 2022: 9,937 shares worth $198K. The stake represents ﹤0.01% of the portfolio and ranks #1903 among its holdings.

153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.

Amalgamated Financial held 9,937 shares of Phibro Animal Health worth $198K as of Q1 2022.
Phibro Animal Health was a new Amalgamated Financial position in Q1 2022.
Phibro Animal Health made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1903 holding.
153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.